TRENTON, N.J.—Major drugmakers, the British government, and a top Alzheimer’s research charity are pooling more than $100 million to create a global fund to accelerate efforts to find a treatment or even a cure for the mind-robbing disease within a decade.
The new Dementia Discovery Fund will function like a venture capital fund. It will identify promising laboratory discoveries in Alzheimer’s disease and other forms of dementia, and then distribute money to cover costs for the steps needed to prepare for and then begin the first tests in patients, what’s called translational research.
The new Dementia Discovery Fund will function like a venture capital fund.
